Cerebellar syndromes: Clinical and experimental study
Details
Status
Open: Currently recruiting participants.
Closed: Recruitment either has not started or has paused or completed.
Study Type
Interventional (clinical trials): Test treatments.
Observational: Conduct surveys and interviews, study medical records and otherwise observe people or groups over time.
Observational
Study Phase
Each study phase tests different aspects of the medication or treatment:
- Phase I: safety and dosing
- Phase II: effectiveness and side effects
- Phase III: efficacy compared to standard treatments
- Phase IV: long-term safety after approval for use
Unspecified
Location(s)
Johns Hopkins study sites. Additional study locations may be found on ClinicalTrials.gov.
The Johns Hopkins Hospital
1800 Orleans St Baltimore, MD 21287
Keywords
Contact Us
Research_Recruitment@jh.eduBrief Summary
Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause imbalance, poor coordination, and speech difficulties. There are different kinds of SCA and this study will focus on types 1, 2,3, and 6 (SCA 1, SCA 2, SCA 3 , also known as Machado-Joseph disease and SCA 6). The diseases are rare, slowly progressive, cause increasingly severe neurological difficulties and are variable across and within genotypes. The purpose of this research study is to bring together a group of experts in the field of SCA for the purpose of learning more about the disease.
The research questions are:
- How does your disease progress over time?
- What are the best ways to measure the progression?
- Do some genes, other than the gene that is abnormal in your disease, have any effect on the way the disease behaves?
This is a nationwide study and we expect that 800 patients will participate all over the USA. The participants will be in the study for an indeterminate period of time. Study visits will be done every 6 or 12 months depending on the participating site.
Eligibility
Inclusion Criteria:
- Presence of symptomatic ataxic disease
- Definite molecular diagnosis of SCA 1, 2,3,or 6 either in the subject or another affected family member
- Willingness to participate in the study and ability to give informed consent.
- Age 6 years and above
Exclusion Criteria:
- Known recessive, X-linked and mitochondrial ataxias
- Exclusion of SCA 1, 2, 3 and 6 by previous DNA testing,
- A lack of willingness to participate in the study